Lakefront Biotherapeutics NV
GLPGF
$28.08
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.42B | 3.52B | 3.63B | 3.63B | 3.56B |
| Total Receivables | 61.89M | 62.47M | 103.16M | 103.16M | 90.24M |
| Inventory | 20.26M | 26.41M | 39.69M | 39.69M | 41.63M |
| Prepaid Expenses | -- | 120.90K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.75M | 6.59M | 49.53M | 49.53M | 57.33M |
| Total Current Assets | 3.51B | 3.62B | 3.82B | 3.82B | 3.75B |
|
|
|||||
| Total Current Assets | 3.51B | 3.62B | 3.82B | 3.82B | 3.75B |
| Net Property, Plant & Equipment | 88.13M | 94.71M | 128.82M | 128.82M | 122.38M |
| Long-term Investments | -- | -- | 81.21M | 81.21M | 75.35M |
| Goodwill | -- | -- | 81.21M | 81.21M | 75.35M |
| Total Other Intangibles | 854.40K | 995.70K | 173.14M | 173.14M | 168.88M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 213.11M | 233.35M | 222.81M | 222.81M | 172.45M |
| Total Assets | 3.86B | 4.00B | 4.48B | 4.48B | 4.35B |
|
|
|||||
| Total Accounts Payable | 109.69M | 38.30M | 156.41M | 156.41M | 182.60M |
| Total Accrued Expenses | -- | 23.50K | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.81M | 2.03M | 2.81M | 2.81M | 3.32M |
| Total Finance Division Other Current Liabilities | 3.52M | 139.13M | 314.01M | 314.01M | 286.45M |
| Total Other Current Liabilities | 3.52M | 139.13M | 314.01M | 314.01M | 286.45M |
| Total Current Liabilities | 115.02M | 179.48M | 473.23M | 473.23M | 472.38M |
|
|
|||||
| Total Current Liabilities | 115.02M | 179.48M | 473.23M | 473.23M | 472.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.56M | 6.09M | 7.11M | 7.11M | 8.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.79M | 14.80M | 898.89M | 898.89M | 896.26M |
| Total Liabilities | 136.36M | 200.36M | 1.38B | 1.38B | 1.38B |
|
|
|||||
| Common Stock & APIC | 3.47B | 3.56B | 3.56B | 3.56B | 3.28B |
| Retained Earnings | 261.52M | 247.24M | -447.21M | -447.21M | -303.52M |
| Treasury Stock & Other | -6.75M | -6.62M | -7.42M | -7.42M | -2.40M |
| Total Common Equity | 3.73B | 3.80B | 3.10B | 3.10B | 2.97B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.73B | 3.80B | 3.10B | 3.10B | 2.97B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.73B | 3.80B | 3.10B | 3.10B | 2.97B |
|
|
|||||